Advertisement
News
Advertisement

Novartis Receives FDA Approval to Market Prevacid(R) 24HR as Firstand Only OTC Proton Pump Inhibitor in Original Prescription Formulation

Thu, 05/14/2009 - 4:53am
Novartis has announced thatPrevacid(R) 24HR (lansoprazole delayed-release capsules 15 mg) has beenapproved by the FDA as the firstOTC Proton Pump Inhibitor (PPI) for the treatment offrequent heartburn since 2003. Prevacid 24HR is expected to be availableover-the-counter in 2009.

Topics

Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading